Allergy Diagnosis and Management
Interpretation of Laboratory Results
- A Class 5 IgE food allergy lab result indicates a very high level of allergen-specific IgE antibodies, strongly suggesting clinical reactivity to the food, but alone is not diagnostic of food allergy and requires correlation with clinical symptoms, as stated by the American Academy of Pediatrics 1, 2
- High IgE levels can indicate sensitization without clinical allergy, with one study finding that 93% of children avoiding foods due to positive test results were actually tolerant of those foods 2
- Age, duration of allergen avoidance, and clinical disorders can affect interpretation of IgE test results, highlighting the need for careful consideration of patient factors 1
- Different laboratory systems may provide significantly different measurements for the same sample, emphasizing the importance of laboratory methods in test interpretation, according to the American Academy of Allergy, Asthma, and Immunology 1
- Higher total IgE levels may affect the interpretation of allergen-specific IgE results, as noted by the American Academy of Allergy, Asthma, and Immunology 3
Allergen Testing
- Allergen testing is most valuable for diagnosing inhalant allergies (pollens, dust mites, animal dander), insect venom allergies, and certain food allergies, as stated by the American Academy of Otolaryngology-Head and Neck Surgery, the Journal of Allergy and Clinical Immunology, and the Mayo Clinic Proceedings 4, 5, 3
- Serum allergen-specific IgE testing is useful when skin testing is contraindicated, such as in patients on antihistamines that cannot be discontinued, extensive dermatitis or dermatographism, or risk of anaphylaxis from skin testing, as recommended by the American Academy of Allergy, Asthma, and Immunology 1
- Available tests for diagnosing allergies include:
- Total Serum IgE and Atopy Patch Test (APT) are not recommended for routine evaluation of food allergies, and Intradermal Testing should not be used to diagnose food allergies, as stated by the American Academy of Allergy, Asthma, and Immunology 1, 7, 8
Medications and Treatment
- Second-generation H1 antihistamines are recommended as first-line therapy for patients with a class 3 RAST positive test and elevated IgE levels, with potential escalation to omalizumab for refractory cases, as recommended by the American Academy of Dermatology and the American College of Allergy, Asthma, and Immunology 7, 9
- Non-sedating second-generation H1 antihistamines can be increased up to four times the standard dose if necessary, and leukotriene receptor antagonists can be considered as adjunctive therapy, though evidence for their efficacy is limited 9, 10
- Omalizumab is indicated for chronic spontaneous urticaria in patients 12 years and older who remain symptomatic despite H1 antihistamine treatment, with dosing based on serum total IgE level and body weight, or fixed dosing for chronic urticaria 10
- For respiratory allergies with positive tests AND symptoms, consider allergen immunotherapy if symptoms are inadequately controlled by medications, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 5
- Avoidance measures, such as minimizing exposure to identified allergens and avoiding aggravating factors, are recommended by the American College of Allergy, Asthma, and Immunology 9
Diagnostic Considerations and Pitfalls
- Testing should be performed in settings where resuscitation facilities are available, as stated by the American Society of Anesthesiologists 11
- Results must be correlated with clinical history for proper diagnosis, according to the American Academy of Otolaryngology-Head and Neck Surgery and the American Academy of Allergy, Asthma, and Immunology 6, 3
- Patients with extensive dermatitis or dermatographism may not be suitable for skin testing, as noted by the American Academy of Allergy, Asthma, and Immunology 3
- Common pitfalls to avoid in the diagnosis and management of chronic allergies and histamine intolerance include overreliance on laboratory testing, unnecessary extensive testing, overuse of systemic corticosteroids, and failure to consider comorbidities, as noted by the British Journal of Dermatology and the American College of Allergy, Asthma, and Immunology 9, 12
Preparation for Testing
- Discontinuing antihistamines like chlorpheniramine, terfenadine, diphenhydramine, or hydroxyzine at least 24 hours to 4 days before testing is recommended to ensure accurate skin prick/intradermal test results, as suggested by the Centers for Disease Control and Prevention and the American Academy of Allergy, Asthma, and Immunology 13, 14, 1
- Astemizole should be discontinued at least 3 weeks before testing to avoid interference with skin test results, as recommended by the Centers for Disease Control and Prevention 13, 14
- Discontinuing Benadryl 3-7 days before testing is recommended when possible, to provide the most reliable results for comprehensive allergy assessment, as suggested by the American Academy of Allergy, Asthma, and Immunology 1
- Histamine controls should always be used with skin testing to validate results and prevent false negatives due to antihistamine effects, as recommended by the Centers for Disease Control and Prevention 15